Trial NCT04400838
Publication Emary K, Lancet, 2021
Primary outcome on the report: Symptomatic COVID-19 disease, defined as a positive NAAT result on an upper airway swab in a participant with at least one symptom, including cough, fever of 37·8°C or higher, shortness of breath, anosmia, or ageusia.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.